Patient safety event reporting in critical care: a study of three intensive care units.

PubWeight™: 1.51‹?› | Rank: Top 4%

🔗 View Article (PMID 17334258)

Published in Crit Care Med on April 01, 2007

Authors

Carolyn B Harris1, Melissa J Krauss, Craig M Coopersmith, Michael Avidan, Patricia A Nast, Marin H Kollef, W Claiborne Dunagan, Victoria J Fraser

Author Affiliations

1: Department of Internal Medicine, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, USA.

Articles by these authors

Targeted versus universal decolonization to prevent ICU infection. N Engl J Med (2013) 13.05

Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis (2012) 7.97

A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med (2005) 6.14

Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest (2003) 5.64

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother (2005) 5.35

Patients' and physicians' attitudes regarding the disclosure of medical errors. JAMA (2003) 4.94

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest (2006) 4.51

Before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med (2006) 4.10

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest (2002) 3.98

The sepsis seesaw: tilting toward immunosuppression. Nat Med (2009) 3.95

Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis (2008) 3.88

Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis (2011) 3.78

The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs (2007) 3.63

Risk factors for surgical site infection following orthopaedic spinal operations. J Bone Joint Surg Am (2008) 3.53

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrob Agents Chemother (2005) 3.49

Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis (2007) 3.21

Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis (2011) 3.20

Pneumonia caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2008) 3.13

Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. JAMA (2012) 3.13

The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med (2009) 3.08

The importance of fluid management in acute lung injury secondary to septic shock. Chest (2009) 2.92

Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy. Crit Care Med (2015) 2.87

Time to Appropriate Antibiotic Therapy Is an Independent Determinant of Postinfection ICU and Hospital Lengths of Stay in Patients With Sepsis. Crit Care Med (2015) 2.86

Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med (2006) 2.76

Herpes zoster risk factors in a national cohort of veterans with rheumatoid arthritis. Clin Infect Dis (2009) 2.74

Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. Crit Care Med (2005) 2.70

Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol (2005) 2.70

Short- and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin Infect Dis (2008) 2.61

Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med (2003) 2.59

Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest (2008) 2.57

Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis. Crit Care Med (2009) 2.57

Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database. Crit Care Med (2006) 2.51

Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother (2007) 2.49

Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock (2007) 2.37

Characteristics and circumstances of falls in a hospital setting: a prospective analysis. J Gen Intern Med (2004) 2.37

Implementation of a real-time computerized sepsis alert in nonintensive care unit patients. Crit Care Med (2011) 2.35

Mandatory influenza vaccination of health care workers: translating policy to practice. Clin Infect Dis (2010) 2.35

Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. Chest (2013) 2.32

ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis (2006) 2.27

A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest (2004) 2.26

Household versus individual approaches to eradication of community-associated Staphylococcus aureus in children: a randomized trial. Clin Infect Dis (2011) 2.22

Endotracheal tube intraluminal volume loss among mechanically ventilated patients. Crit Care Med (2004) 2.20

Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol (2006) 2.19

Risk factors for surgical site infection in spinal surgery. J Neurosurg (2003) 2.17

Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay. Crit Care Med (2011) 2.16

Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. Am J Respir Crit Care Med (2010) 2.15

Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. JPEN J Parenter Enteral Nutr (2002) 2.15

Occurrence of co-colonization or co-infection with vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol (2004) 2.13

Relationship between tracheostomy timing and duration of mechanical ventilation in critically ill patients. Crit Care Med (2005) 2.09

Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. Chest (2009) 2.09

Pneumonia Pathogen Characterization Is an Independent Determinant of Hospital Readmission. Chest (2015) 2.09

Effectiveness of an educational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: a 4-year study. Clin Infect Dis (2007) 2.07

Treatment-related risk factors for hospital mortality in Candida bloodstream infections. Crit Care Med (2008) 2.06

A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther (2007) 2.05

Attitudes of respiratory therapists and nurses about measures to prevent ventilator-associated pneumonia: a multicenter, cross-sectional survey study. Respir Care (2007) 2.03

Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis (2006) 1.97

Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis. Clin Infect Dis (2005) 1.95

A multicenter intervention to prevent catheter-associated bloodstream infections. Infect Control Hosp Epidemiol (2006) 1.93

Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients. Crit Care Med (2005) 1.92

IL-15 prevents apoptosis, reverses innate and adaptive immune dysfunction, and improves survival in sepsis. J Immunol (2009) 1.91

Nonrandom selection and the attributable cost of surgical-site infections. Infect Control Hosp Epidemiol (2002) 1.90

Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics (2005) 1.89

Economic implications of an evidence-based sepsis protocol: can we improve outcomes and lower costs? Crit Care Med (2007) 1.88

Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment. Crit Care Med (2006) 1.86

A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria. Crit Care Med (2012) 1.82

Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest (2008) 1.81

Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy. Crit Care Med (2006) 1.80

Mitochondrial resuscitation with exogenous cytochrome c in the septic heart. Crit Care Med (2007) 1.76

Ventilator-associated pneumonia in extremely preterm neonates in a neonatal intensive care unit: characteristics, risk factors, and outcomes. Pediatrics (2003) 1.76

Characterization and modulation of the immunosuppressive phase of sepsis. Infect Immun (2010) 1.76

Effects of age on mortality and antibiotic efficacy in cecal ligation and puncture. Shock (2003) 1.73

The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med (2010) 1.73

Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol (2010) 1.73

Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med (2002) 1.72

Effects of aging on the immunopathologic response to sepsis. Crit Care Med (2009) 1.72

Inappropriate therapy for methicillin-resistant Staphylococcus aureus: resource utilization and cost implications. Crit Care Med (2008) 1.72

Antimicrobial stewardship in the intensive care unit: advances and obstacles. Am J Respir Crit Care Med (2009) 1.71

Prevalence and cost of full-time research fellowships during general surgery residency: a national survey. Ann Surg (2009) 1.71

Choosing your words carefully: how physicians would disclose harmful medical errors to patients. Arch Intern Med (2006) 1.69

Risk factors for surgical site infection after low transverse cesarean section. Infect Control Hosp Epidemiol (2008) 1.69

Risk managers, physicians, and disclosure of harmful medical errors. Jt Comm J Qual Patient Saf (2010) 1.69

Implementing a commercial rule base as a medication order safety net. J Am Med Inform Assoc (2005) 1.69

The impact of prebiopsy antibiotics on pathogen recovery in hematogenous vertebral osteomyelitis. Clin Infect Dis (2011) 1.69

US and Canadian physicians' attitudes and experiences regarding disclosing errors to patients. Arch Intern Med (2006) 1.68

Cancer causes increased mortality and is associated with altered apoptosis in murine sepsis. Crit Care Med (2010) 1.68